Pharmaceutical recruitment agencies were alerted by GlaxoSmithKline news that they wish to create a further 1000 UK jobs. This news would have pleased the government which introduced tax incentives to promote the UK as a country that innovates.
The “patent box” scheme means that any UK-owned intellectual property, implying patents has huge reductions in corporation tax. This incentive is by and large aimed at the pharmaceutical industry which runs its business on patenting its products.
The worry was a few years ago that other countries such as Holland were leading the way in attracting growth in Pharmaceuticals. However with almost a U-Turn view in UK’s approach, means that GSK will develop its first new manufacturing facility in the UK for 25 years.
The £500m facility in Hertfordshire will expand its current respiratory drug plant and also be a biopharmaceutical manufacturing plant. GSK will also be setting up a £50m venture capital fund for early stage healthcare companies that need investing in to grow, which will be a welcome boost to healthcare companies and healthcare recruitment agencies.


